{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:06:17Z","timestamp":1791407177993,"version":"4.3.3"},"reference-count":74,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":5496,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of nutrition, health and aging"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1007\/bf03028618","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T09:55:51Z","timestamp":1688378151000},"page":"703-713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Rapid cognitive decline in Alzheimer's disease. Consensus paper"],"prefix":"10.1016","volume":"12","author":[{"given":"M.E.","family":"Soto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Arbus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ceccaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Couratier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dantoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. -F.","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Gillette-guyonette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nourhashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. -J.","family":"Ousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Poncet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Portet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Touchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/BF03028618_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ageing\/32.2.200","article-title":"Long-term cognitive and functional decline in late onset Alzheimer's disease: therapeutic implications","volume":"32","author":"Holmes","year":"2003","journal-title":"Age and Aging"},{"key":"10.1007\/BF03028618_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-Mental-Test: a practical method for grading the cognitive state of patient for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1007\/BF03028618_bib3","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1212\/WNL.43.12.2457","article-title":"The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib4","first-page":"86","article-title":"Recent Data on the natural history of Alzheimer disease: Results from the REAL.FR study","volume":"9","author":"Cortes","year":"2005","journal-title":"J Nutr Health Aging"},{"key":"10.1007\/BF03028618_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/archneur.1994.00540150069019","article-title":"\u201cHow far\u201d vs \u201chow fast\u201d in Alzheimer's disease","volume":"51","author":"Kraemer","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib6","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/01.WNL.0000094327.68399.59","article-title":"Rate of cognitive decline and mortality in Alzheimer's disease","volume":"61","author":"Hui","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib7","first-page":"163","article-title":"Predictive factors for rapid loss on the Mini-Mental State Examination in Alzheimer's disease","volume":"9","author":"Dumont","year":"2005","journal-title":"J Nutr Health Aging"},{"key":"10.1007\/BF03028618_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archneur.60.8.1137","article-title":"The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer's disease","volume":"60","author":"Holtzer","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archneur.58.3.449","article-title":"A method for estimating progression rates in Alzheimer's disease","volume":"58","author":"Doody","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/089198870201500409","article-title":"Which Alzheimer patients are at risk for rapid cognitive decline?","volume":"15","author":"O'Hara","year":"2002","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1007\/BF03028618_bib11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.acn.2003.12.011","article-title":"Investigation of profile difference between Alzheimr's disease patients declining at different rates: Examination of baseline neuropsychological data","volume":"19","author":"Atchinson","year":"2004","journal-title":"Arch Clin Neuropsychol"},{"key":"10.1007\/BF03028618_bib12","doi-asserted-by":"crossref","unstructured":"Helmer C, Andrieu S, P\u00e9r\u00e8s K, Orgogozo JM, Vellas B, Dartigues JF. Predictive value of decline in ADAS-cog for survival without severe Alzheimer's disease. Dement Geriatr Cogn Disor 2007:168\u2013174","DOI":"10.1159\/000098516"},{"key":"10.1007\/BF03028618_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jalz.2006.03.002","article-title":"Aggressive course of disease in dementia","volume":"2","author":"Gauthier","year":"2006","journal-title":"Alzheimer's and Dementia"},{"key":"10.1007\/BF03028618_bib14","doi-asserted-by":"crossref","first-page":"345s","DOI":"10.1016\/S0248-8663(03)80694-X","article-title":"FR. Baisse rapide du Mini-Mental State Examination: etude REAL.FR","volume":"24","author":"Dumont","year":"2003","journal-title":"Rev Med Int"},{"key":"10.1007\/BF03028618_bib15","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer's disease","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1007\/BF03028618_bib16","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archneur.58.3.417","article-title":"Response of patients with Alzheimer's disease to rivastigmine treatment is predicted by the rate of disease progression","volume":"58","author":"Farlow","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib17","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000087301","article-title":"Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: Results of a meta-analysis","volume":"20","author":"Farlow","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/BF03028618_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000105162","article-title":"Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease","volume":"24","author":"Wilkinson","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/BF03028618_bib19","first-page":"158","article-title":"Rapid cognitive decline: searching for a definition and predictive factor among elderly with Alzheimer's disease","volume":"9","author":"Soto","year":"2005","journal-title":"J Nutr Health Aging"},{"key":"10.1007\/BF03028618_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archneur.56.7.857","article-title":"Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer's disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's disease","volume":"56","author":"Clark","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000102017","article-title":"Fast cognitive decline at the time of dementia diagnosis: a major prognostic factor for survival in the community","volume":"23","author":"Carcaillon","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/BF03028618_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000144073","article-title":"Predictive Value of Rapid Decline in Mini-Mental State Examination in Clinical Practice for Prognosis in Alzheimer's disease","volume":"26","author":"Soto","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/BF03028618_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10072-004-0322-4","article-title":"Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages?","volume":"25","author":"Capitani","year":"2004","journal-title":"Neurol Sci"},{"key":"10.1007\/BF03028618_bib24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.JGP.0000230660.39635.68","article-title":"Strategies to reduce site differences in multisite studies: a case study of Alzheimer disease progression","volume":"14","author":"Noda","year":"2006","journal-title":"Am J Geriatr Psyquiatry"},{"key":"10.1007\/BF03028618_bib25","first-page":"8","article-title":"Age at onset on Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline","volume":"40","author":"Jacobs","year":"1990","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib26","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1097\/00001756-200210070-00028","article-title":"Age at onset is associated with disease severity in Lewy body variant and in Alzheimer's disease","volume":"13","author":"Ho","year":"2002","journal-title":"Neuroreport"},{"key":"10.1007\/BF03028618_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/ana.410320311","article-title":"Inverse relation-ship between education and parietotemporal perfusion deficit in Alzheimer's disease","volume":"32","author":"Stern","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1007\/BF03028618_bib28","doi-asserted-by":"crossref","first-page":"M49","DOI":"10.1093\/gerona\/50A.1.M49","article-title":"Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline","volume":"50","author":"Teri","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1007\/BF03028618_bib29","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1212\/WNL.53.9.1942","article-title":"Rate of memory decline in AD is related to education and occupation: Cognitive reserve?","volume":"53","author":"Stern","year":"1999","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib30","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1212\/01.wnl.0000278163.82636.30","article-title":"Education delays accelerated decline on a memory test in persons who develop dementia","volume":"69","author":"Hall","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/gps.1168","article-title":"A longitudinal study of Alzheimer's disease: rates of cognitive decline and functional decline","volume":"19","author":"Guk-Hee","year":"2004","journal-title":"Int J Geriatr Psy"},{"key":"10.1007\/BF03028618_bib32","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.2007.164.6.910","article-title":"Nursing home placement, day care use, and cognitive decline in Alzheimer's disease","volume":"164","author":"Wilson","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1007\/BF03028618_bib33","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1212\/01.wnl.0000260697.66617.59","article-title":"Cognitive decline in Alzheimer's disease: impact of spirituality, religiosity, and QOL","volume":"68","author":"Kaufman","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/WAD.0b013e31815a9dbb","article-title":"Nutritional status is associated with disease progression in very mild Alzheimer's disease","volume":"22","author":"Ousset","year":"2008","journal-title":"Alz Dis Assoc Disord"},{"key":"10.1007\/BF03028618_bib35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.1994.00540190056015","article-title":"Extrapiramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease","volume":"51","author":"Chui","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib36","first-page":"251","article-title":"Cognitive decline in patients with Alzheimer's disease: differences in patients with and without extrapiramidal signs","volume":"5","author":"Miller","year":"1991","journal-title":"Alzheimer Dis"},{"key":"10.1007\/BF03028618_bib37","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.1997.00550200033007","article-title":"Extrapiramidal signs in patients with probable Alzheimer's disease","volume":"54","author":"Lopez","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib38","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","article-title":"Motor signs during course of Alzheimer's disease","volume":"63","author":"Scarmeas","year":"2004","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10072-007-0830-0","article-title":"Are hallucinations and extrapiramidal signs associated with a steeper cognitive decline in degenerative dementia patients?","volume":"28","author":"Capitani","year":"2007","journal-title":"Neurol Sci"},{"key":"10.1007\/BF03028618_bib40","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib41","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000017239","article-title":"Predictors of cognitive decline in the early stage of probably Alzheimer's disease","volume":"11","author":"Marra","year":"2000","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/BF03028618_bib42","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/j.1468-1331.2007.01693.x","article-title":"Cognitive and behavioural predictors of progression rates in Alzheimer's disease","volume":"14","author":"Buccione","year":"2007","journal-title":"European Journal of Neurology"},{"key":"10.1007\/BF03028618_bib43","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/gps.748","article-title":"Which factors influence cognitive decline in older adults suffering from dementing disorders?","volume":"17","author":"Shaufele","year":"2002","journal-title":"Int J Geriatr Pychiatry"},{"key":"10.1007\/BF03028618_bib44","first-page":"246","article-title":"Letter and category fluency in Alzheimer's disease: a prognosis indicator of progression","volume":"7","author":"Coen","year":"1996","journal-title":"Dementia"},{"key":"10.1007\/BF03028618_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1076\/anec.9.1.1.838","article-title":"Do primary and secondary measures of semantic memory predict cognitive decline in Alzheimer's disease?","volume":"9","author":"Beatty","year":"2002","journal-title":"Aging, Neuropsychology, and Cognition"},{"key":"10.1007\/BF03028618_bib46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000090251","article-title":"Hallucinations, cognitive decline, and death in Alzheimer's disease","volume":"26","author":"Wilson","year":"2005","journal-title":"Neuroepidemiology"},{"key":"10.1007\/BF03028618_bib47","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1212\/WNL.42.9.1689","article-title":"Predictors of cognitive and functional progression in patients with Alzheimer's disease","volume":"42","author":"Mortimer","year":"1992","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib48","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1001\/archneur.64.12.1755","article-title":"Disruptive behavior as a predictor in Alzheimer Disease","volume":"64","author":"Scarmeas","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0891988706286505","article-title":"Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease","volume":"19","author":"Bhargava","year":"2006","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1007\/BF03028618_bib50","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1212\/01.wnl.0000240129.46080.53","article-title":"Relationship of vascular risk to the progression of Alzheimer disease","volume":"67","author":"Regan","year":"2006","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib51","unstructured":"Abellan G, Rolland Y, Nourhash\u00e9mi F, Cantet C, Andrieu S, Vellas B. Cardiovascular risk factors and progression of Alzheimer's disease. Alz Dis Assoc Disord. In press"},{"key":"10.1007\/BF03028618_bib52","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1212\/01.wnl.0000279520.59792.fe","article-title":"Vascular factors predict rate of progression in Alzheimer disease","volume":"69","author":"Mielke","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/aje\/kwm116","article-title":"Smoking as a risk for dementia and cognitive decline: a meta-analyses of prospective studies","volume":"166","author":"Anstey","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1007\/BF03028618_bib54","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1194\/jlr.M400486-JLR200","article-title":"Lipid homeostasis and apolipoprotein E in the development and progression in Alzheimer's disease","volume":"46","author":"Lane","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1007\/BF03028618_bib55","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/01.wnl.0000304038.37421.cc","article-title":"APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease","volume":"70","author":"Consentino","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1192\/bjp.180.2.131","article-title":"Genotype and phenotype in Alzheimer's disease","volume":"180","author":"C","year":"2002","journal-title":"Br J Psy"},{"key":"10.1007\/BF03028618_bib57","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1212\/01.wnl.0000188871.74093.12","article-title":"APOE alleles predict the rate of cognitive decline in Alzheimer's disease","volume":"65","author":"Martins","year":"2005","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib58","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/jnnp.2004.039321","article-title":"Rate of progression of cognitive decline in Alzheimer's disease: Effect of butyrylcholinesterase K gene variation","volume":"76","author":"Holmes","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/BF03028618_bib59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008571-200304000-00008","article-title":"Regulation of attention and response to therapy in dementia by butyrylcholinesterase","volume":"13","author":"O'Brien","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1007\/BF03028618_bib60","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.WNL.0000110315.26026.EF","article-title":"RC. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD","volume":"62","author":"Jack","year":"2004","journal-title":"Neurology"},{"key":"10.1007\/BF03028618_bib61","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1212\/01.wnl.0000303960.01039.43","article-title":"VBM anticipates the rate of progression of Alzheimer disease: a 3-year longitudinal study","volume":"70","author":"Kinkingn\u00e9hun","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/BF03028618_bib62","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jnnp.2003.019273","article-title":"White matter hyperintensities are significantly associated with cortical atrophy in Alzheimer's disease","volume":"75","author":"Capizzano","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/BF03028618_bib63","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/archneur.65.9.1202","article-title":"Measuring cerebral atrophy and white matter hyperintensity burden predict the rate of cognitive decline in Alzheimer disease","volume":"65","author":"Brickman","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000070851","article-title":"Cerebral correlates of the progression rate of the cognitive decline in probable Alzheimer's disease","volume":"50","author":"Nagahama","year":"2003","journal-title":"Eur Neurol"},{"key":"10.1007\/BF03028618_bib65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2006.09.014","article-title":"CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment","volume":"251","author":"Stefani","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1007\/BF03028618_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000093261","article-title":"Stability of CSF beta-amyloid (1\u201342) and tau levels by APOE genotype in Alzheimer disease patients","volume":"22","author":"Huey","year":"2006","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1007\/BF03028618_bib67","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archneur.65.6.776","article-title":"Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease","volume":"65","author":"Locascio","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1007\/BF03028618_bib68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/gerona\/61.5.516","article-title":"Outcome of Alzheimer's disease potential impact of cholinesterase inhibitors","volume":"61","author":"Gillette-Guyonnet","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"Suppl A","key":"10.1007\/BF03028618_bib69","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjopharm.2006.10.001","article-title":"Recommendations for best practices in the treatment of Alzheimer's disease in managed care","volume":"4","author":"Fillit","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"10.1007\/BF03028618_bib70","first-page":"1903","article-title":"Managing Alzheimer's disease: global care and support program","volume":"55","author":"Nourhash\u00e9mi","year":"2005","journal-title":"Rev Prat"},{"key":"10.1007\/BF03028618_bib71","unstructured":"California Workgroup on guidelines for Alzheimer's Disease Management. Guidelines for Alzheimer's disease management. 2002"},{"key":"10.1007\/BF03028618_bib72","first-page":"2234","article-title":"Guidelines for managing Alzheimer's disease: part II. Treatment","volume":"65","author":"Cummings","year":"2002","journal-title":"Am Fam Physician"},{"key":"10.1007\/BF03028618_bib73","unstructured":"NICE: National Institute for Health and Clinical Excellence. Donepezil, rivastigmine, galantamine and memantine for the treatment of Alzheimer's disease (amended); September 2007. Available at: http:\/\/www.nice.org. uk\/guidance\/index.jsp? action=download\u225736556"},{"key":"10.1007\/BF03028618_bib74","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/jnnp.2005.063388","article-title":"Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease","volume":"76","author":"Masse","year":"2005","journal-title":"J Neurol Neurosurg Psyquiatry"}],"container-title":["The Journal of nutrition, health and aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03028618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF03028618\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723023345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1279770723023345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03028618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T13:05:14Z","timestamp":1761138314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1279770723023345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1279770723023345"],"URL":"https:\/\/doi.org\/10.1007\/bf03028618","relation":{},"ISSN":["1279-7707"],"issn-type":[{"value":"1279-7707","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid cognitive decline in Alzheimer's disease. Consensus paper","name":"articletitle","label":"Article Title"},{"value":"The Journal of nutrition, health and aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/BF03028618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 SERDI Publisher.","name":"copyright","label":"Copyright"}]}}